Novartis receives FDA approval of Tekamlo(TM), a single-pill combination of ... - MarketWatch (press release) PDF Print
MarketWatch (press release)Clinical trials with Tekamlo in hypertension excluded patients with severe renal impairment. Clinical trials of aliskiren in hypertension excluded patients

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.